Bloomberg News

Roche Is Preparing Second Large Dalcetrapib Study, Soriot Says

October 13, 2011

Oct. 13 (Bloomberg) -- Roche Holding AG is preparing a second large study of dalcetrapib, its drug for so-called good cholesterol, in patients at risk of a cardiovascular event, Pascal Soriot, head of the Basel, Switzerland-based drugmaker’s pharma unit, said in a conference call today.

To contact the editor responsible for this story: Naomi Kresge at

The Good Business Issue
blog comments powered by Disqus